advertisement
Abstract #15154 Published in IGR 8-4
On the socio-economic relevance of glaucoma
Grub M; Rohrbach JMKlinische Monatsblätter für Augenheilkunde 2006; 223: 793-795
About 800,000 people in Germany suffer from glaucoma. As the population ages, the prevalence of glaucoma will rise and the socio-economic impact of the disease increase. The costs of glaucoma include those of diagnosis, medical, laser and surgical treatment, and costs of blindness as a result of glaucoma. So far the costs of diagnosis and screening programs are not well known but there is substantial knowledge of the therapeutic costs. Daily therapy costs are about 0.50 to 1.00 euro per patient. Every year the German statutory health insurance system pays about 1,000 euro per glaucoma patient. In addition, blindness due to glaucoma costs the German government over euro 150 million annually in Social Security benefits, lost income tax revenues, and health care expenditures. Demographic changes and scientific progress will even aggravate the socio-economic burden of this disease. LA: German
Dr. M. Grub, Abteilung 1, Universitätsaugenklinik Tübingen, Tübingen, Germany. matthias.grueb@med.uni-tuebingen.de
Classification:
14 Costing studies; pharmacoeconomics
